Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Definium Therapeutics, Inc. - Common Shares
(NQ:
DFTX
)
37.40
-0.20 (-0.53%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Definium Therapeutics, Inc. - Common Shares
< Previous
1
2
3
Next >
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
February 19, 2026
From
Definium Therapeutics, Inc.
Via
Business Wire
Definium Therapeutics Announces New Employee Inducement Grants
February 02, 2026
From
Definium Therapeutics, Inc.
Via
Business Wire
Definium Therapeutics Appoints Roger Adsett to Board of Directors
January 29, 2026
From
Definium Therapeutics, Inc.
Via
Business Wire
Definium Therapeutics Announces New Employee Inducement Grants
January 26, 2026
From
Definium Therapeutics, Inc.
Via
Business Wire
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care
January 20, 2026
From
Definium Therapeutics, Inc.
Via
Business Wire
2026 Asset Growth: Why Federal Compliance Is the New Metric
January 19, 2026
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC.
From
Equity Insider
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.